Statistics

Total Visits

Views
Gemcitabine and Capecitabine as Third- or Later-line Therapy for Refractory Advanced Colorectal Cancer: A Retrospective Study52

Select a period of time:

Number of views in the range

Views
Gemcitabine and Capecitabine as Third- or Later-line Therapy for Refractory Advanced Colorectal Cancer: A Retrospective Study31

Views

Views
January 20252
February 20252
March 202513
April 20252
May 20251
June 202510
July 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore13
Hong Kong11
United States4
Brazil1
Spain1
United Kingdom1
 

Top cities views

Views
Hong Kong11
Birigui1
Council Bluffs1
Dallas1
Pasadena1